Literature DB >> 15261344

Apoptosis in rheumatoid arthritis: friend or foe.

Hongtao Liu1, Richard M Pope.   

Abstract

A better understanding of the mechanisms that contribute to the resistance of synovial macrophages and fibroblasts to apoptosis will not only provide better insights into the mechanisms contributing to the perpetuation of rheumatoid arthritis (RA) but will also help identify targets for the development of novel, more effective, and long-lasting therapies for the treatment of patients with RA. To avoid toxicity, such as the induction of apoptosis of critical organs, the mechanisms by which these molecules are targeted and therapy delivered must be carefully selected, using the insights obtained from studies characterizing the mechanisms that promote chronic inflammation.

Entities:  

Mesh:

Year:  2004        PMID: 15261344     DOI: 10.1016/j.rdc.2004.04.010

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  14 in total

1.  Ursolic acid facilitates apoptosis in rheumatoid arthritis synovial fibroblasts by inducing SP1-mediated Noxa expression and proteasomal degradation of Mcl-1.

Authors:  Eugene Y Kim; Kuladeep Sudini; Anil K Singh; Mahamudul Haque; Douglas Leaman; Sadik Khuder; Salahuddin Ahmed
Journal:  FASEB J       Date:  2018-05-25       Impact factor: 5.191

2.  Anti-arthritic effects of FasL gene transferred intra-articularly by an inducible lentiviral vector containing improved tet-on system.

Authors:  Qingyu Shi; Xuebi Tian; Yinlin Zhao; Huiyu Luo; Yuke Tian; Ailin Luo
Journal:  Rheumatol Int       Date:  2011-07-27       Impact factor: 2.631

3.  Intracellular Signaling Pathways in Rheumatoid Arthritis.

Authors:  Charles J Malemud
Journal:  J Clin Cell Immunol       Date:  2013-08-19

4.  Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis.

Authors:  John C Scatizzi; Jack Hutcheson; Richard M Pope; Gary S Firestein; Alisa E Koch; Melissa Mavers; Avraham Smason; Hemant Agrawal; G Kenneth Haines; Navdeep S Chandel; Richard S Hotchkiss; Harris Perlman
Journal:  Arthritis Rheum       Date:  2010-02

5.  Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis.

Authors:  Otilia May Yue Koo; Israel Rubinstein; Hayat Onyüksel
Journal:  Pharm Res       Date:  2010-12-04       Impact factor: 4.200

6.  A novel apoptosis probe, cyclic ApoPep-1, for in vivo imaging with multimodal applications in chronic inflammatory arthritis.

Authors:  In-Seop So; Jin Hee Kang; Jung Wan Hong; Shijin Sung; Al Faruque Hasan; Keum Hee Sa; Seung Woo Han; In San Kim; Young Mo Kang
Journal:  Apoptosis       Date:  2021-03-03       Impact factor: 4.677

Review 7.  Innate immunity and rheumatoid arthritis.

Authors:  Angelica Gierut; Harris Perlman; Richard M Pope
Journal:  Rheum Dis Clin North Am       Date:  2010-05       Impact factor: 2.670

8.  Down-regulation of myeloid cell leukemia 1 by epigallocatechin-3-gallate sensitizes rheumatoid arthritis synovial fibroblasts to tumor necrosis factor alpha-induced apoptosis.

Authors:  Salahuddin Ahmed; Matthew D Silverman; Hubert Marotte; Kevin Kwan; Natalie Matuszczak; Alisa E Koch
Journal:  Arthritis Rheum       Date:  2009-05

Review 9.  BH3-only proteins in rheumatoid arthritis: potential targets for therapeutic intervention.

Authors:  J Hutcheson; H Perlman
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

10.  Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways.

Authors:  Fabrizio Montecucco; Maria Bertolotto; Luciano Ottonello; Alessandra Quercioli; François Mach; Franco Dallegri
Journal:  J Biomed Biotechnol       Date:  2009-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.